LEADER 01556nam  2200421Ia 450 
001 9910698979703321
005 20090617145026.0
035   $a(CKB)5470000002398076
035   $a(OCoLC)401784386
035   $a(EXLCZ)995470000002398076
100   $a20090617d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eQ7A good manufacturing practice guidance for active pharmaceutical ingredients
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2001]
215   $aiv, 52 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on June 17, 2009).
300   $a"ICH".
300   $a"August 2001".
517   $aGuidance for industry 
606   $aDrug factories$xQuality control
606   $aPharmaceutical chemistry
606   $aDrugs$xQuality control
615  0$aDrug factories$xQuality control.
615  0$aPharmaceutical chemistry.
615  0$aDrugs$xQuality control.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698979703321
996   $aGuidance for industry$93434577
997   $aUNINA